PKCα-specific Phosphorylation of the Troponin Complex in Human Myocardium: a Functional and Proteomics Analysis
Overview
Authors
Affiliations
Aims: Protein kinase Cα (PKCα) is one of the predominant PKC isoforms that phosphorylate cardiac troponin. PKCα is implicated in heart failure and serves as a potential therapeutic target, however, the exact consequences for contractile function in human myocardium are unclear. This study aimed to investigate the effects of PKCα phosphorylation of cardiac troponin (cTn) on myofilament function in human failing cardiomyocytes and to resolve the potential targets involved.
Methods And Results: Endogenous cTn from permeabilized cardiomyocytes from patients with end-stage idiopathic dilated cardiomyopathy was exchanged (∼69%) with PKCα-treated recombinant human cTn (cTn (DD+PKCα)). This complex has Ser23/24 on cTnI mutated into aspartic acids (D) to rule out in vitro cross-phosphorylation of the PKA sites by PKCα. Isometric force was measured at various [Ca(2+)] after exchange. The maximal force (Fmax) in the cTn (DD+PKCα) group (17.1±1.9 kN/m(2)) was significantly reduced compared to the cTn (DD) group (26.1±1.9 kN/m(2)). Exchange of endogenous cTn with cTn (DD+PKCα) increased Ca(2+)-sensitivity of force (pCa50 = 5.59±0.02) compared to cTn (DD) (pCa50 = 5.51±0.02). In contrast, subsequent PKCα treatment of the cells exchanged with cTn (DD+PKCα) reduced pCa50 to 5.45±0.02. Two PKCα-phosphorylated residues were identified with mass spectrometry: Ser198 on cTnI and Ser179 on cTnT, although phosphorylation of Ser198 is very low. Using mass spectrometry based-multiple reaction monitoring, the extent of phosphorylation of the cTnI sites was quantified before and after treatment with PKCα and showed the highest phosphorylation increase on Thr143.
Conclusion: PKCα-mediated phosphorylation of the cTn complex decreases Fmax and increases myofilament Ca(2+)-sensitivity, while subsequent treatment with PKCα in situ decreased myofilament Ca(2+)-sensitivity. The known PKC sites as well as two sites which have not been previously linked to PKCα are phosphorylated in human cTn complex treated with PKCα with a high degree of specificity for Thr143.
Abnormal phosphorylation / dephosphorylation and Ca dysfunction in heart failure.
Liu Y, Wang Q, Song Y, Song X, Fan Y, Kong L Heart Fail Rev. 2024; 29(4):751-768.
PMID: 38498262 DOI: 10.1007/s10741-024-10395-w.
Abrams S, Alhamdi Y, Zi M, Guo F, Du M, Wang G Int J Mol Sci. 2023; 24(4).
PMID: 36834636 PMC: 9967552. DOI: 10.3390/ijms24043225.
The role of antibody-based troponin detection in cardiovascular disease: A critical assessment.
Ma H, Cassedy A, OKennedy R J Immunol Methods. 2021; 497:113108.
PMID: 34329690 PMC: 8412434. DOI: 10.1016/j.jim.2021.113108.
Putative role of natural products as Protein Kinase C modulator in different disease conditions.
Singh R, Kumar S, Tomar M, Verma P, Kumar A, Kumar S Daru. 2021; 29(2):397-414.
PMID: 34216003 PMC: 8602708. DOI: 10.1007/s40199-021-00401-z.
Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy.
Dorsch L, Schuldt M, Dos Remedios C, Schinkel A, de Jong P, Michels M Cells. 2019; 8(7).
PMID: 31323898 PMC: 6678711. DOI: 10.3390/cells8070741.